Timi Edeki

2.0k citations

41 papers · 1.6k indexed · h-index 19

Impact in

Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy

Papers in ⓘ

Molecular Medicine 7
- Antibiotic Resistance in Bacteria 7
Pharmacology 11
- Antibiotics Pharmacokinetics and Efficacy 14
- Pharmacogenetics and Drug Metabolism 10

Co-authors: Nu He (7 shared papers)Shampa Das (7 shared papers)Joyce A. Goldstein (2 shared papers)Patrick Griffith (2 shared papers)Lindsay A. Farrer (2 shared papers)Rodney C.P. Go (2 shared papers)L. Adrienne Cupples (2 shared papers)David Bachman (2 shared papers)
Journals: Clinical Pharmacology & Therapeutics (4 papers)The Journal of Clinical Pharmacology (4 papers)European Journal of Clinical Pharmacology (3 papers)American Journal of Therapeutics (2 papers)International Journal of Antimicrobial Agents (2 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Timi Edeki

41 papers receiving 1.5k citations

Peers

Countries citing papers authored by Timi Edeki

Since Specialization

Citations

This map shows the geographic impact of Timi Edeki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timi Edeki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timi Edeki more than expected).

Fields of papers citing papers by Timi Edeki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timi Edeki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timi Edeki. The network helps show where Timi Edeki may publish in the future.

Co-authors

The 25 scholars most cited alongside Timi Edeki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Timi Edeki Line = papers co-authored together Timi Edeki links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Depression as a Risk Factor for Alzheimer Disease Archives of Neurology ·Robert C. Green, L. Adrienne Cupples, A Kurz, Sanford Auerbach, Rodney C.P. Go, A. Dessa Sadovnick, Ranjan Duara, Walter A. Kukull, Helena Chui, Timi Edeki, Patrick Griffith, Robert P. Friedland, David Bachman, Lindsay A. Farrer	2003	429
2	Identification of a null allele of CYP2C9 in an African–American exhibiting toxicity to phenytoin Pharmacogenetics ·Robert S. Kidd, Timothy B. Curry, Susan Gallagher, Timi Edeki, Joyce Blaisdell, Joyce A. Goldstein	2001	196
3	International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms Clinical Pharmacology & Therapeutics ·Kathleen M. Giacomini, Praveen Balimane, Sangeun Cho, Michael T. Eadon, Timi Edeki, Kathleen M. Hillgren, S-M Huang, Yuichi Sugiyama, Dietmar Weitz, Yujia Wen, Chenxi Xia, Sook Wah Yee, Heike Zimdahl, Mikko Niemi	2013	120
4	Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimens Journal of Antimicrobial Chemotherapy ·David P. Nicolau, Leonard Siew, J. Armstrong, James Li, Timi Edeki, Maria Learoyd, Shampa Das	2015	106
5	Association Between Apolipoprotein E Genotype and Alzheimer Disease in African American Subjects Archives of Neurology ·Neill R. Graff‐Radford, Robert C. Green, Rodney C.P. Go, Michael Hutton, Timi Edeki, David Bachman, Jennifer Adamson, Patrick Griffith, Floyd B. Willis, Mary Williams, Yvonne G. Hipps, Jonathan L. Haines, L. Adrienne Cupples, Lindsay A. Farrer	2002	76
6	The Inhibitory Effects of Herbal Components on CYP2C9 and CYP3A4 Catalytic Activities in Human Liver Microsomes American Journal of Therapeutics ·Nu He, Timi Edeki	2004	70
7	Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients Antimicrobial Agents and Chemotherapy ·John S. Bradley, J. Armstrong, Antonio Arrieta, Raafat Bishai, Shampa Das, Shirley Delair, Timi Edeki, William C. Holmes, Jianguo Li, Kathryn Moffett, Deepa Mukundan, Norma Pérez, José R. Romero, David Speicher, Janice E. Sullivan, Diansong Zhou	2016	46
8	Assessment of the Mass Balance Recovery and Metabolite Profile of Avibactam in Humans and In Vitro Drug-Drug Interaction Potential Drug Metabolism and Disposition ·Karthick Vishwanathan, Stuart Mair, Anshul Gupta, James Atherton, J.A. Clarkson-Jones, Timi Edeki, Shampa Das	2014	42
9	Genetic polymorphism of S-mephenytoin 4??-hydroxylation in African-Americans Pharmacogenetics ·Timi Edeki, Joyce A. Goldstein, Sonia M. F. de Morais, Leila Hajiloo, Marcela Butler, Perry Chapdelaine, G. Wilkinson	1996	41
10	PhRMA White Paper on ADME Pharmacogenomics The Journal of Clinical Pharmacology ·J. Andrew Williams, Tommy Andersson, Tommy B. Andersson, Rebecca Blanchard, Martin O. Behm, Nadine Cohen, Timi Edeki, Monique Franc, Kathleen M. Hillgren, Keith Johnson, David A. Katz, Mark Milton, Bernard P. Murray, Joseph W. Polli, Deb Ricci, Lisa A. Shipley, Vangala Subrahmanyam, Steven Wrighton	2008	37
11	Randomized pharmacokinetic and drug–drug interaction studies of ceftazidime, avibactam, and metronidazole in healthy subjects Pharmacology Research & Perspectives ·Shampa Das, Jianguo Li, J. Armstrong, Maria Learoyd, Timi Edeki	2015	34
12	Phase I study assessing the safety, tolerability, and pharmacokinetics of avibactam and ceftazidime–avibactam in healthy Japanese volunteers Journal of Infection and Chemotherapy ·N. Tominaga, Timi Edeki, James Li, Maria Learoyd, M. René Bouw, Shampa Das	2015	31
13	Increased Baseline Sway Contributes to Increased Losses of Balance in Older People Following Triazolam Journal of the American Geriatrics Society ·Deborah W. Robin, Samer S. Hasan, Timi Edeki, Michael J. Lichtenstein, Richard Shiavi, Alastair J.J. Wood	1996	28
14	Randomized, placebo‐controlled study to assess the impact on QT/QTc interval of supratherapeutic doses of ceftazidime–avibactam or ceftaroline fosamil–avibactam The Journal of Clinical Pharmacology ·Shampa Das, J. Armstrong, David Mathews, Jianguo Li, Timi Edeki	2013	27
15	EFFECTS OF INDIVIDUAL GINSENOSIDES, GINKGOLIDES AND FLAVONOIDS ON CYP2C19 AND CYP2D6 ACTIVITY IN HUMAN LIVER MICROSOMES Clinical and Experimental Pharmacology and Physiology ·Nu He, Hong‐Guang Xie, Xavier Collins, Timi Edeki, Zhengyin Yan	2006	25
16	A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock Critical Care ·Peter E. Morris, Brian Zeno, Andrew C. Bernard, Xiangning Huang, Shampa Das, Timi Edeki, Steven G. Simonson, Gordon R. Bernard	2012	24
17	Evaluation of the potential for pharmacokinetic interaction between fenofibrate and ezetimibe: A phase I, open-label, multiple-dose, three-period crossover study in healthy subjects Clinical Therapeutics ·Linda E. Gustavson, Sarah M. Schweitzer, David Burt, Ramanuj Achari, Matthew J. Rieser, Timi Edeki, Titus Chira, H. Daniel Yannicelli, Maureen T. Kelly	2006	22
18	American Society for Clinical Pharmacology and Therapeutics Position Statement on Dietary Supplement Safety and Regulation* Clinical Pharmacology & Therapeutics ·Jason D. Morrow, Timi Edeki, Mohamed El Mouelhi, Raymond E. Galinsky, Rose Kovelesky, Robert J. Noveck, Charles Preuss	2005	20
19	Sensitive assay for triazolam in plasma following low oral doses Journal of Chromatography B Biomedical Sciences and Applications ·Timi Edeki, Deborah W. Robin, Chandra Prakash, Ian A. Blair, Alastair J.J. Wood	1992	18
20	Inhibitory effects of H1-antihistamines on CYP2D6- and CYP2C9-mediated drug metabolic reactions in human liver microsomes European Journal of Clinical Pharmacology ·Nu He, Wenqi Zhang, Dolores C. Shockley, Timi Edeki	2002	17

About Timi Edeki

Timi Edeki is a scholar working on Molecular Medicine, Pharmacology, Pharmacology, Complementary and alternative medicine and Family Practice, having authored 41 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Pharmacogenetics and Drug Metabolism (10 papers), Antibiotic Resistance in Bacteria (7 papers), Pneumonia and Respiratory Infections (7 papers), Drug Transport and Resistance Mechanisms (6 papers), Pharmacological Effects and Toxicity Studies (5 papers), Ginkgo biloba and Cashew Applications (5 papers) and Analytical Methods in Pharmaceuticals (4 papers). The work is most often cited by research in Molecular Medicine (265 citations), Pharmacology (394 citations), Applied Microbiology and Biotechnology (75 citations), Biological Psychiatry (87 citations) and Pharmacology (450 citations). Timi Edeki has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Nu He, Shampa Das, Joyce A. Goldstein, Patrick Griffith, Lindsay A. Farrer, Rodney C.P. Go, L. Adrienne Cupples, David Bachman, Robert C. Green and Joyce Blaisdell. Their work appears in journals such as Clinical Pharmacology & Therapeutics, The Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology, American Journal of Therapeutics and International Journal of Antimicrobial Agents.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact